Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03185247
Other study ID # 17-0470
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 26, 2017
Est. completion date September 1, 2019

Study information

Verified date September 2019
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed intervention is focused on developing and implementing a psychological approach incorporated into a group-based outpatient intervention for pediatric autonomic dysfunction. The investigators hypothesize that their intervention will result in improvements in the transdiagnostic mechanisms specifically targeted by components of their intervention including sleep, information processing, and youth/parent experiential avoidance.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date September 1, 2019
Est. primary completion date March 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 18 Years
Eligibility Inclusion Criteria:

- Adolescent participants must be

1. between the ages of 13-18 years old,

2. english speaking, and

3. have been diagnosed with autonomic dysfunction, dysautonomia, orthostatic intolerance, and/or POTS.

- Participants must also:

1. endorse symptoms of autonomic dysfunction on the COMPASS 31 (measures are described below), and show

2. moderate functional impairment, and/or

3. some psychiatric symptoms in the domains of anxiety and/or depression.

- FDI scores must be greater than 12 (see Kashikar-Zuck et al., 2011 for an empirical rationale).

- Must have attended at least one day of school per week during the past month.

- On the measures of anxiety (SCARED) and depression (CDI), the adolescent's scale score must be above the "average" range based on T scores (CDI) or within the "clinical" range (SCARED).

- Each participant must have at least one English-speaking parent/legal guardian who can provide informed consent for the adolescent, as well as participate in the study.

- Each adolescent and their parent/legal guardian(s) must be English-speaking.

Exclusion Criteria:

- Adolescent participants;

1. wards of the state,

2. endorse active homicidal or suicidal ideation,

3. have an intellectual disability, a pervasive developmental disability or significant developmental delay,

4. endorse an active substance use disorder, and

5. are currently participating in individual or group psychotherapy.

6. do not have in-network health insurance that covers Health and Behavior interventions, or

7. are unable to self-pay.

- Parent/legal guardian(s) are

1. unwilling to participate in the study,

2. are non-English speaking, or

3. have an intellectual disability, a pervasive developmental disability or significant developmental delay, and/or

4. do not have legal custody of the adolescent participant.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Transdiagnostic Group-Based Treatment
10 week 90-minute weekly therapy sessions including both the adolescent and caregiver. Treatment will consist of psychoeducation about dysautonomia, motivational interviewing techniques to promote readiness for change, support around lifestyle and behavioral changes, core CBT components (e.g., relaxation training, linking thoughts, feelings, and behaviors, minimizing catastrophizing thoughts, cognitive coping, and exposure), and components of ACT aiming to increase cognitive flexibility (e.g., mindfulness, experiential avoidance, values, cognitive defusion, committed action), and relapse prevention and maintenance. Most sessions will involve homework assigned to the adolescent and their parent/legal guardian(s) to encourage practice at home.

Locations

Country Name City State
United States Children's Hospital Colorado Aurora Colorado

Sponsors (1)

Lead Sponsor Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Composite Autonomic Symptom Score (self-report) This is a 31 item self-report measure developed to assess autonomic symptoms (e.g., dizziness, orthostatic intolerance, nausea, sweating). Baseline, 10 weeks, and 6-months
Primary Change in Functional Disability Inventory (caregiver and self-report) This is a measure that evaluates children's difficulty in physical and psychosocial functioning due to their physical health. The instrument consists of 15 items that assess self-perceptions of activity limitations during the past 2 weeks. Baseline, 10 weeks, and 6-months
Primary Change in Children's Depression Inventory (caregiver and self-report) This is a 27-item self-report measure designed to assess cognitive, behavioral, and affective symptoms of depression. Baseline, 10 weeks, and 6-months
Primary Change in Screen for Childhood Anxiety Related Emotional Disorders (caregiver and self-report) This measure is used to screen for childhood anxiety disorders including general anxiety disorder, separation anxiety disorder, panic disorder and social phobia. In addition, it assesses symptoms related to school refusal. The SCARED consists of 41 items. Baseline, 10 weeks, and 6-months
Primary Change in Transdiagnostic Youth/Parent Questionnaire Our team developed these comprehensive questionnaires to assess transdiagnostic mechanisms in the present study. These questionnaires comprise full measures and/or subscales drawn from several well-validated and psychometrically-sound measures that are available as part of the public domain and/or that were provided for open access by the developers of the measure, and that have been previously designed and validated to measure each of the mechanisms of interest. These mechanisms include emotion regulation, experiential avoidance, sleep, peer acceptance/rejection, parenting, and information processing. Baseline, 10 weeks, and 6-months
Primary Change in Pain Coping Questionnaire (caregiver and self-report) For the current study, this measure has been adapted to ask about "physical illness symptoms" rather than pain. The adapted measure asks adolescents/caregivers to indicate how often (1 = never to 5 = very often) they/their child used each of 39 coping strategies when responding to prompts such as, "When I am experiencing autonomic symptoms for a few hours or days, I…" Baseline, 10 weeks, and 6-months
Primary Satisfaction Questionnaire (caregiver and self-report) This is an 8-item measure intended to assess satisfaction, perceived benefits, and likelihood of recommending the program. Items, which include "How would you rate the quality of care you have received?" are rated on a 1 to 4 Likert-scale. 10 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A